Shasha Guan Linlin Zhang Junyan Zhang Wenjing Song Diansheng Zhong
10.3389/fimmu.2022.1068978
Front Immunol
2023 Jan 4;13:1068978.
bullous pemphigoid immune checkpoint inhibitor intravenous immunoglobulin lung carcinoma pembrolizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36685586/
Carcinoma, Non-Small-Cell Lung / drug therapy Lung Neoplasms / complications Lung Neoplasms / drug therapy Pemphigoid, Bullous / chemically induced Pemphigoid, Bullous / diagnosis Pemphigoid, Bullous / drug therapy
Carcinoma, Non-Small-Cell Lung / drug therapy Lung Neoplasms / complications Lung Neoplasms / drug therapy Pemphigoid, Bullous / chemically induced Pemphigoid, Bullous / diagnosis Pemphigoid, Bullous / drug therapy Case Reports Aged Blister / drug therapy Humans Immune Checkpoint Inhibitors / adverse effects Male Steroids / therapeutic use Immune Checkpoint Inhibitors Steroids
PMC9845947
36685586
A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy
2023